KAMADA - is a developer of life saving therapeutics. A global specialty plasma-derived biopharmaceutical company with a diverse portfolio of marketed products, a robust
development pipeline and industry-leading manufacturing capabilities. The Company’s strategy is focused on driving profitable growth from its current
commercial products, its plasma-derived...
Pay attention to the day of February 10 when the estimated results for 2020 are announced.
If they are positive, then the price will rise to 8.90 and then the next monthly resistance from 10usd
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company...
Kamada Provides Update on Progress Related to its Proprietary Hyper-Immunoglobulin (IgGs) Platform Technology including its Commercial Anti-Rabies IgG and its Pipeline Products Anti-Corona (COVID-19) and Anti-Zika IgGs
Rehovot, Israel, March 11, 2020 – Kamada Ltd. (NASDAQ & TASE: KMDA), a commercial-stage plasma-derived biopharmaceutical company, today provided an...
thank you for your appreciation to do business and looking for stocks and stock markets and to check on the security information to provide some identification to get access granted to check the email for any circumstances to the flash drive
